- Home
- WLFC vs CRMD Comparison
WLFC vs CRMD Comparison
Compare WLFC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLFC
- CRMD
- Stock Information
- Founded
- WLFC 1985
- CRMD 2006
- Country
- WLFC United States
- CRMD United States
- Employees
- WLFC N/A
- CRMD N/A
- Industry
- WLFC Industrial Specialties
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- WLFC Consumer Discretionary
- CRMD Health Care
- Exchange
- WLFC Nasdaq
- CRMD Nasdaq
- Market Cap
- WLFC 983.1M
- CRMD 877.5M
- IPO Year
- WLFC 1996
- CRMD 2010
- Fundamental
- Price
- WLFC $137.68
- CRMD $11.28
- Analyst Decision
- WLFC
- CRMD Strong Buy
- Analyst Count
- WLFC 0
- CRMD 7
- Target Price
- WLFC N/A
- CRMD $17.33
- AVG Volume (30 Days)
- WLFC 177.1K
- CRMD 2.2M
- Earning Date
- WLFC 07-31-2025
- CRMD 08-13-2025
- Dividend Yield
- WLFC 0.70%
- CRMD N/A
- EPS Growth
- WLFC 66.69
- CRMD N/A
- EPS
- WLFC 14.50
- CRMD 0.28
- Revenue
- WLFC $594,146,000.00
- CRMD $82,553,827.00
- Revenue This Year
- WLFC $16.35
- CRMD $238.38
- Revenue Next Year
- WLFC $10.53
- CRMD $53.52
- P/E Ratio
- WLFC $9.79
- CRMD $40.46
- Revenue Growth
- WLFC 35.29
- CRMD N/A
- 52 Week Low
- WLFC $67.58
- CRMD $3.61
- 52 Week High
- WLFC $235.43
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- WLFC 47.23
- CRMD 39.54
- Support Level
- WLFC $134.70
- CRMD $11.13
- Resistance Level
- WLFC $142.12
- CRMD $11.86
- Average True Range (ATR)
- WLFC 6.66
- CRMD 0.65
- MACD
- WLFC -0.34
- CRMD -0.34
- Stochastic Oscillator
- WLFC 31.13
- CRMD 3.81
About WLFC Willis Lease Finance Corporation
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.